TipRanks
Ondine Biomedical, Inc. (DE:VF5)
FRANKFURT:VF5
Germany Market
VF5
Ondine Biomedical, Inc.
RESEARCH TOOLSreports

Ondine Biomedical, Inc. (VF5) Income Statement

2 Followers

Ondine Biomedical, Inc. Income Statement

Last quarter (Q2 2026), Ondine Biomedical, Inc.'s total revenue was C$1.23M, an increase of 42.16% from the same quarter last year. In Q2, Ondine Biomedical, Inc.'s net income was C$-15.96M. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 2.65MC$ 2.05MC$ 1.20MC$ 638.00KC$ 2.57M
Gross Profit
C$ 1.09MC$ 1.32MC$ 703.00KC$ 287.00KC$ 1.25M
Operating Expenses
C$ 31.13MC$ 20.77MC$ 15.51MC$ 19.05MC$ 18.77M
Depreciation and Amortization
C$ 591.43KC$ 565.00KC$ 587.00KC$ 493.00KC$ 514.00K
EBITDA
C$ -29.45MC$ -18.49MC$ -13.79MC$ -18.85MC$ -48.36M
Operating Income
C$ -30.04MC$ -19.44MC$ -14.80MC$ -18.76MC$ -17.52M
Other Income/Expenses
C$ 451.09KC$ 346.00KC$ 393.00KC$ -609.00KC$ -32.56M
Pretax Income
C$ -29.59MC$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09M
Net Income
C$ -29.59MC$ -19.10MC$ -14.41MC$ -19.37MC$ -50.09M
Per Share Metrics
Basic EPS
C$ -0.06C$ -0.07C$ -0.07C$ -0.10C$ -0.26
Diluted EPS
C$ -0.06C$ -0.07C$ -0.07C$ -0.10C$ -0.26
Weighted Average Shares Outstanding
 465.08M 274.60M 197.11M 194.59M 194.59M
Weighted Average Shares Outstanding (Diluted)
 465.08M 274.60M 197.11M 194.59M 194.59M
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History